**Begins on or after June 27, 2023**
What You Need To Know
What is the new training requirement?
The Medication Access and Training Expansion (MATE) Act states that all DEA-licensed practitioners complete eight hours of training on the treatment and management of patients with opioid or other substance use disorders.
Who is affected?
All DEA-registered practitioners, except for practitioners that are solely veterinarians.
What is the training completion date?
The one-time training requirement must be satisfied on or after June 27, 2023 with a regularly scheduled renewal date or an initial DEA registration. The requirement will not be necessary for any subsequent renewal registrations.
What does the MMS offer to meet the requirement?
NEJM Knowledge+ Pain Management and Opioids, a free, online 10-hour course meets the MATE Act training
requirement and provides practitioners with confidence that they are following guidelines when treating patients. The course can be completed in intervals that work with your schedule.
Are there other options to meet the requirement?
These groups of practitioners are deemed to have satisfied this training:
Group 1: All practitioners that are board certified in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, the American Board of Addiction Medicine, or the American Osteopathic Association.
Group 2: All practitioners that graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and completed a comprehensive
curriculum that included at least eight hours of training on:
- Treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; or
- Safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders
Practitioners can satisfy this training by engaging in a total of eight hours of training on the treatment and management of patients with opioid or other substance use disorders from the organizations listed below. Note:
- The training can be cumulative across multiple sessions equaling eight hours of training
- Past training on the treatment and management of patients with opioid or other substance use disorders can count towards meeting this requirement
- Past DATA-waived trainings count towards the 8-hour training requirement
- Training can occur in a variety of formats, including classroom settings, seminars at professional society meetings, or virtual offerings
Organizations offering programming:
- American Medical Association (AMA)
- The AMA Education Hub provides Substance Use Disorders and Addiction Education that meet the DEA requirements
- The American Society of Addiction Medicine (ASAM)
- The American Academy of Addiction Psychiatry (AAAP)
- American Medical Association (AMA)
- The American Osteopathic Association (AOA), or any organizations accredited by the AOA to provide continuing medical education
- The American Dental Association (ADA)
- The American Association of Oral and Maxillofacial Surgeons (AAOMS)
- The American Psychiatric Association (APA)
- The American Association of Nurse Practitioners (AANP)
- The American Academy of Physician Associates (AAPA)
- The American Nurses Credentialing Center (ANCC)
- Any other organization accredited by the Accreditation Council for Continuing Medical Education (ACCME) or the Commission for Continuing Education Provider Recognition (CCEPR), whether
directly or through an organization accredited by a State medical society that is recognized by the ACCME or CCEPR
- Any other organization approved or accredited by the Assistant Secretary for Mental Health and Substance Use, the ACCME, or the CCEPR
Resources
